Literature DB >> 27193295

Virulence Attributes and Antifungal Susceptibility Profile of Opportunistic Fungi Isolated from Ophthalmic Infections.

Hafize Sav1, Havva Gül Ozdemir2, Rabiye Altınbas3, Nuri Kiraz3, Macit Ilkit4, Seyedmojtaba Seyedmousavi5,6,7,8.   

Abstract

Investigations of both virulence factors and antifungal susceptibility profiles are crucial for understanding the pathogenesis and prognosis of ophthalmic mycoses. In this study, we investigated the in vitro antifungal susceptibility of amphotericin B (AMB), voriconazole (VRC), and natamycin (NAT) against a set of 50 fungal isolates obtained from patients with ocular mycoses using the Clinical and Laboratory Standards Institute broth microdilution method. In addition, putative virulence factor, such as secretory phospholipases and proteinases, and biofilm formation activity were analyzed. The geometric means (GMs) of the minimum inhibitory concentrations (MICs) of the antifungals across all isolates were the following (in increasing order): VRC (0.70 μg/mL), AMB (0.81 μg/mL), and NAT (1.05 μg/mL). The highest activity against 14 Aspergillus strains was exhibited by VRC (GM MIC: 0.10 μg/mL), followed by AMB and NAT (GM MICs: 0.21 and 0.27 μg/mL), respectively. However, for 12 Fusarium spp., the GM MIC of VRC (2.66) was higher than those of NAT and AMB (GM MICs 1.3 and 0.8 μg/mL, respectively). Proteinase and phospholipase activity were observed in 30 % and 42 % of the isolates, respectively, whereas only 8 % of the isolates were able to produce biofilms. Phospholipase activity was observed in all Fusarium isolates, but not in any of the Aspergillus isolates. In contrast, biofilm-forming capability was detected in 25 % of the Fusarium isolates, but none of the Aspergillus isolates. The differences in the MICs of AMB, VRC, and NAT, biofilm-forming ability and proteinase and phospholipase activities among the isolates were not significant (p > 0.05). Overall, our study suggests no significant correlation between the antifungal susceptibility profiles and virulence attributes of ocular fungal isolates.

Entities:  

Keywords:  Antifungal susceptibility testing; Ocular fungal isolates; Virulence factors

Mesh:

Substances:

Year:  2016        PMID: 27193295     DOI: 10.1007/s11046-016-0018-3

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  33 in total

1.  Characterization of fusarium keratitis outbreak isolates: contribution of biofilms to antimicrobial resistance and pathogenesis.

Authors:  Pranab K Mukherjee; Jyotsna Chandra; Changping Yu; Yan Sun; Eric Pearlman; Mahmoud A Ghannoum
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-07-03       Impact factor: 4.799

2.  Fusarium keratitis in South India: causative agents, their antifungal susceptibilities and a rapid identification method for the Fusarium solani species complex.

Authors:  Mónika Homa; Coimbatore S Shobana; Yendrembam R B Singh; Palanisamy Manikandan; Kanesan P Selvam; László Kredics; Venkatapathy Narendran; Csaba Vágvölgyi; László Galgóczy
Journal:  Mycoses       Date:  2013-02-26       Impact factor: 4.377

3.  The enterococcal surface protein, Esp, is involved in Enterococcus faecalis biofilm formation.

Authors:  A Toledo-Arana; J Valle; C Solano; M J Arrizubieta; C Cucarella; M Lamata; B Amorena; J Leiva; J R Penadés; I Lasa
Journal:  Appl Environ Microbiol       Date:  2001-10       Impact factor: 4.792

4.  Intravitreal voriconazole for the treatment of endogenous Aspergillus endophthalmitis.

Authors:  Michal Kramer; Mordechai R Kramer; Hannah Blau; Jihad Bishara; Ruth Axer-Siegel; Dov Weinberger
Journal:  Ophthalmology       Date:  2006-05-19       Impact factor: 12.079

Review 5.  Current perspectives on ophthalmic mycoses.

Authors:  Philip A Thomas
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

6.  Fusarium keratitis: genotyping, in vitro susceptibility and clinical outcomes.

Authors:  Rafael A Oechsler; Michael R Feilmeier; Darlene Miller; Wei Shi; Ana Luisa Hofling-Lima; Eduardo C Alfonso
Journal:  Cornea       Date:  2013-05       Impact factor: 2.651

Review 7.  Voriconazole in the treatment of fungal eye infections: a review of current literature.

Authors:  S M Hariprasad; W F Mieler; T K Lin; W E Sponsel; J R Graybill
Journal:  Br J Ophthalmol       Date:  2008-07       Impact factor: 4.638

Review 8.  Fungal keratitis.

Authors:  M Srinivasan
Journal:  Curr Opin Ophthalmol       Date:  2004-08       Impact factor: 3.761

9.  Plate method for detection of phospholipase activity in Candida albicans.

Authors:  M F Price; I D Wilkinson; L O Gentry
Journal:  Sabouraudia       Date:  1982-03

10.  Microscopic evaluation, molecular identification, antifungal susceptibility, and clinical outcomes in fusarium, Aspergillus and, dematiaceous keratitis.

Authors:  Devarshi U Gajjar; Anuradha K Pal; Bharat K Ghodadra; Abhay R Vasavada
Journal:  Biomed Res Int       Date:  2013-10-24       Impact factor: 3.411

View more
  3 in total

1.  Biofilm Formation and Resistance to Fungicides in Clinically Relevant Members of the Fungal Genus Fusarium.

Authors:  Hafize Sav; Haleh Rafati; Yasemin Öz; Burcu Dalyan-Cilo; Beyza Ener; Faezeh Mohammadi; Macit Ilkit; Anne D van Diepeningen; Seyedmojtaba Seyedmousavi
Journal:  J Fungi (Basel)       Date:  2018-01-23

2.  Delayed-onset post-operative keratitis and endophthalmitis caused by Exophiala oligosperma.

Authors:  Laurie W van der Merwe; Dawood da Costa; Kessendri Reddy; David Meyer
Journal:  J Ophthalmic Inflamm Infect       Date:  2021-12-23

3.  Efficacy of Voriconazole Corneal Intrastromal Injection for the Treatment of Fungal Keratitis.

Authors:  Chenshuang Li; Kunpeng Pang; Liqun Du; Xinyi Wu
Journal:  J Ophthalmol       Date:  2021-07-30       Impact factor: 1.909

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.